Biomerica, Inc. (BMRA)
Makes diagnostic test kits that detect diseases and food intolerances from blood or stool samples.
$1.60-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-50.5%
The outlook
BMRA is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting downward momentum. Analyst coverage appears minimal. The stock sits at the very bottom of its recent yearly range, signaling sustained weakness.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$4.9M
52-wk high
$4.60
52-wk low
$1.57
50-day avg
$1.95
200-day avg
$2.27
Trailing P/E
—